The Triallogix Team
Our clinical research team combines scientific expertise with compassionate care. We are proud to uphold the highest industry standards, delivering reliable data and exceptional support for every clinical trial.

Kevin Oei, D.O.
.png)
Arjun Makam, D.O.
.png)
Joanna Chan, M.D.
.png)
The Clinical Staff
.png)
The Research Team
Sponsors Our Investigators Have Worked With
































Why Work With Triallogix?
Triallogix is led by an actively practicing physician with direct oversight of study conduct, patient safety, and protocol adherence. Our clinical decision-making remains centralized, responsive, and aligned with sponsor and CRO expectations—ensuring efficient issue resolution and consistent execution.
We leverage an existing clinical patient population and structured screening processes to support efficient and compliant enrollment. Our approach emphasizes patient education, visit adherence, and long-term engagement, resulting in strong retention and reduced protocol deviations.
Our site is purpose-built with standardized workflows, established SOPs, and trained research staff to support predictable performance across studies. We prioritize operational discipline, accurate feasibility assessments, and realistic enrollment commitments—reducing variability and execution risk for sponsors.
Triallogix maintains organized, continuously updated regulatory files and source documentation to support audit and inspection readiness at all times. We emphasize proactive compliance rather than reactive correction, supporting clean monitoring visits and smooth closeout processes.
Triallogix values clear, timely communication with sponsors and CROs. We provide prompt feasibility responses, consistent updates, and early escalation of risks or challenges. Sponsors work directly with a site that takes ownership of outcomes—not one that defers responsibility.
Frequently
Asked Questions
Have questions about joining a clinical trial? Here are some of the most common things people want to know before they participate.

.png)
Triallogix operates as a multi-specialty clinical research site with a focus on outpatient, community-based clinical trials. Our site is well suited for Phase II–IV studies, including vaccine, infectious disease, chronic disease, and cardiology trials. We prioritize protocols that align with our patient population and operational capabilities to ensure reliable enrollment and high-quality execution.

.png)
Triallogix conducts all studies in accordance with ICH-GCP guidelines, FDA regulations, and sponsor-specific requirements. Our site maintains standardized SOPs, structured source documentation practices, and rigorous internal quality controls. Regulatory files are actively maintained to ensure audit and inspection readiness throughout the life of each study.

.png)
Triallogix is structured to support efficient study startup and activation. We can start up as soon as 2 weeks. We provide timely feasibility responses, rapid regulatory document completion, and proactive communication with sponsors and CROs. Our internal workflows are designed to minimize delays and ensure predictable startup timelines without compromising compliance.

.png)
Triallogix leverages an established patient database and structured screening workflows to support accurate and compliant patient enrollment, as well as a sophisticated social media outreach strategy. Recruitment projections are data-driven and conservative, with an emphasis on eligibility accuracy and retention. Our site prioritizes patient education, visit adherence, and protocol compliance to reduce dropouts and protocol deviations.

.png)
Triallogix combines the clinical oversight of an actively practicing physician-led site with the operational discipline of a purpose-built research organization. Our site emphasizes clear sponsor communication, reliable enrollment execution, and regulatory rigor. We focus on long-term sponsor relationships by delivering consistent performance across studies rather than overextending on volume.


